Samir Melki, MD, PHD completed a fellowship in Cornea and Refractive Surgery at MEEI in 2000. His previous education included a BS from the American University in Beirut, an MD PhD from Vanderbilt University and an Ophthalmology residency at Georgetown University.
Dr. Melki founded the Boston Eye Group in 2000 and has pursued an academically-oriented practice since. He joined the Cornea service at MEEI in 2007 as a part-time faculty. Dr. Melki is the Medical Director for Ophthalmology at the UK specialist hospitals where he has established and managed quality controls for about 20,000 cataract procedures since 2005.
Dr. Melki actively participates in the fellowship program at MEEI. His other teaching activities include a fellowship program at the Boston Eye Group and a collaboration with Boston University to tutor students undergoing a Masters in Health Sciences. His clinical practice is oriented towards refractive surgery as well as cataract and corneal surgery. He has performed more than 11,000 refractive procedures since 1998. His academic activities have led to several accomplishments. These include the publication of many peer-reviewed articles, 3 textbooks as well as regular participation in various courses at US and international meetings.
Dr. Melki designed several surgical instruments, was the first surgeon to implant a phakic IOL in Boston and was the first person to implant a device during cataract surgery to wirelessly measure intraocular pressure in a patient with glaucoma. He has been key to introducing Keratoprosthesis surgery to Lebanon and South West England. Dr. Melki's most recent research endeavors include his participation in a clinical trial to measure the effect of corneal collagen crosslinking on keratoconus patients.
Board certification: American Board of Ophthalmology
Hospital affiliation: Bidco